Pharmacist-led telehealth disease management program for patients with diabetes and depression
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Introduction: The aim of this study was to determine whether a pharmacist-led telehealth disease management program is superior to usual care of nurse-led telehealth in improving diabetes medication adherence, haemoglobin A1C (A1C), and depression scores in patients with concomitant diabetes and depression. Methods: Patients with diabetes and depression were randomized to pharmacist-led or nurse-led telehealth. Veterans with type 1 or type 2 diabetes, an A1C ≥ 7.5%, diagnosis of depression, and access to a landline phone were invited to participate. Patients were randomized to usual care of nurse-led telehealth or pharmacist-led telehealth. Patients were shown how to use the telehealth equipment by the nurse or pharmacist. In the pharmacist-led group, the patients received an in-depth medication review in addition to the instruction on the telehealth equipment. Results: After six months, the pharmacist-led telehealth arm showed significant improvements for cardiovascular medication adherence (14.0; 95% confidence interval (CI) 0.4 to 27.6), antidepressant medication adherence (26.0; 95% CI 0.9 to 51.2), and overall medication adherence combined (13.9; 95% CI 6.6 to 21.2) from baseline to six-month follow-up. There was a significant difference in A1C between each group at the six-month follow-up in the nurse-led telehealth group (6.9 ± 0.9) as compared to the pharmacist-led telehealth group (8.8 ± 2.0). There was no significance in the change in patient health questionnaire-9 (PHQ-9) and Center for Epidemiologic Studies Depression Scale (CES-D) from baseline to follow-up in both groups. Discussion: Pharmacist-led telehealth was efficacious in improving medication adherence for cardiovascular, antidepressants, and overall medications over a six-month period as compared to nurse-led telehealth. There was no significant improvement in overall depression scores.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various interventions with specific strategies targeting the underlying disparities resulting from social factors have been shown to be effective in reducing the burden posed by SDOH.1669,1670”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1670]
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
The Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926 · cited 1×
“The prevalence of concurrent major depression and significant depressive symptoms in patients with diabetes mellitus is estimated to be 11% and 31%, respectively – roughly two times the rate of the general population.(1) Their interaction has been recognized as particularly problematic as each condition negatively inf…”
BackgroundDepression and Diabetes: Impact of Depressive Symptoms on Adherence, Function, and Costs
Ciechanowski, P. S., Katon, W. J., & Russo, J. E. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3278 · Cited by 1,465
Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1836 · Cited by 1,135
Lee, J. K., Grace, K. A., & Taylor, A. J. (2006) · JAMA · doi:10.1001/jama.296.21.joc60162 · Cited by 807
Ziegelstein, R. C., Fauerbach, J. A., Stevens, S. S., Romanelli, J., Richter, D. P., & Bush, D. E. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.12.1818 · Cited by 710
Depression in diabetic patients
Lustman, P. J., & Clouse, R. E. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.01.002 · Cited by 578 · cited 1×
“Multiple studies have shown an association between depression in diabetes and worse treatment adherence(8,9) and worse glucose control.(2,10) Poor adherence and worse disease control among those with diabetes and depression can be explained, in part, by the patient’s low level of confidence in their ability to engage…”
BackgroundLustman, P. J., Griffith, L. S., Freedland, K. E., Kissel, S. S., & Clouse, R. E. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-8-199810150-00005 · Cited by 562
Behavioral and Clinical Factors Associated With Depression Among Individuals With Diabetes
Katon, W., Von Korff, M., Ciechanowski, P., Russo, J., Lin, E., Simon, G., Ludman, E., Walker, E., Bush, T., & Young, B. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.914 · Cited by 456
Research works printed but not linked: 5
- Kalsekar ID, 2006, Manag Care Interface, 19, 39
- Lustman PJ, 2005, J Diabetes Complications, 19, 113
- Barnett TE, 2006, Am J Manag Care, 12, 467
- Davis TC, 1993, Fam Med, 25, 391
- Piette JD, 2004, Am J Manag Care, 10, 152
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Konnyu, K. J., Yogasingam, S., Lépine, J., Sullivan, K., Alabousi, M., Edwards, A., Hillmer, M., Karunananthan, S., Lavis, J. N., Linklater, S., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014513 · Cited by 37
Shah, A., Hussain‐Shamsy, N., Strudwick, G., Sockalingam, S., Nolan, R. P., & Seto, E. (2022) · Journal of Medical Internet Research · doi:10.2196/38030 · Cited by 42
“A study reported significant changes in patients’ health behavior (medication adherence [95]) and another in health care provider behavior (depression screening [76]).”
Pharmacist-Managed Diabetes Programs: Improving Treatment Adherence and Patient Outcomes
Orabone, A. W., Do, V., & Cohen, E. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s342936 · Cited by 53
“In another model, pharmacists educated patients on a phone application that provided daily prompts to remind patients to take their medications and complete daily diabetes self-care tasks.(35) RPM devices like continuous glucose monitoring (CGM) have also gained wide popularity to improve accessibility to health care…”
BackgroundLeiz, M., Pfeuffer, N., Rehner, L., Stentzel, U., & van den Berg, N. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s388106 · Cited by 36
“There seems to be no difference in terms of effectiveness between nurse-led and pharmacist-led eHealth interventions.(52) However, studies comparing different interventions or components in terms of their cost-effectiveness are lacking.”
BackgroundInfluentialTelepharmacy: A Potential Alternative Approach for Diabetic Patients During the COVID-19 Pandemic
Iftinan, G. N., Wathoni, N., & Lestari, K. (2021) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s325645 · Cited by 38
Iftinan, G. N., Elamin, K. M., Rahayu, S. A., Lestari, K., & Wathoni, N. (2023) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s400734 · Cited by 38
Effectiveness of telepharmacy diabetes services: A systematic review and meta-analysis
Cao, D. X., Tran, R. J. C., Yamzon, J., Stewart, T. L., & Hernandez, E. A. (2022) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxac070 · Cited by 31
Perceived Versus Demonstrated Understanding of the Complex Medications of Medically Complex Children
Blackmer, A. B., Fox, D. A., Arendt, D., Phillips, K., & Feinstein, J. A. (2021) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-26.1.62 · Cited by 21
Evolution of Telehealth—Its Impact on Palliative Care and Medication Management
Imam, S. N., Braun, U. K., Garcia, M. A., & Jackson, L. K. (2024) · Pharmacy · doi:10.3390/pharmacy12020061 · Cited by 24
“Studies in diabetic, cardiovascular, and depression management have shown that pharmacist-led telehealth improves medication adherence as compared to nurse-led telehealth [8].”
BackgroundDescribing the delivery of clinical pharmacy services via telehealth: A systematic review
Melton, T. C., Jasmin, H., Johnson, H. F., Coley, A. K., Duffey, S., & Renfro, C. P. (2021) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1486 · Cited by 24
“2%) utilized CPAs and CMMs in combination.(35,42,43,49,50,54) Seventeen studies (28.”
BackgroundMethodInfluentialFranquez, R. T., Moura, M. D. G., McClung, D. C. F., Barberato-Filho, S., Lopes, L. C., Silva, M. T., Fiol, F. D. S. D., & Bergamaschi, C. D. C. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110854 · Cited by 16
Gürçay, B., Yılmaz, F. T., & Bilgin, A. (2023) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2023.0088 · Cited by 19
Synchronous telepharmacy models of care for adult outpatients: A systematic review
Snoswell, C. L., Guzman, K. R. D., Neil, L. J., Isaacs, T., Mendis, R., Taylor, M. L., & Ryan, M. I. (2024) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2024.10.005 · Cited by 14
Martin, M., Patterson, J., Allison, M., O’Connor, B. B., & Patel, D. K. (2021) · JMIR Diabetes · doi:10.2196/24981 · Cited by 17
“The findings reported here are consistent with the study hypothesis and align with emerging evidence on digital health coaching intervention outcomes [20-32].”
BackgroundResultPharmacies providing health services: Attitudes toward eHealth in Italy
Cobelli, N., Cassia, F., Zardini, A., & Kuppelwieser, V. G. (2023) · Journal of Retailing and Consumer Services · doi:10.1016/j.jretconser.2023.103568 · Cited by 15
Lammila-Escalera, E., Greenfield, G., Pan, Z., Nicholls, D., Majeed, A., & Hayhoe, B. W. J. (2024) · British Journal of General Practice · doi:10.3399/bjgp.2023.0406 · Cited by 15
“Of the 11 trials (Supplementary Table S2), nine 34–36, 38– 42 , Three studies 40,42,44 were deemed as being of good quality, five studies 36,37,39,41,43 were considered to be of fair quality, and three studies 34,35,38 were assessed as being of poor quality (Supplementary Table S3).”
Pharmacist-Led Digital Health Interventions for Patients with Diabetes: A Systematic Review
Christy, A., Fernanda, F., Insani, W. N., & Abdulah, R. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s494584 · Cited by 11
“8,18 The effectiveness of the intervention is influenced by several factors, including its practicability and patient engagement, the frequency of intervention, the provision of personalized communication, and the integration with clinical care through automation.”
Grauer, A., Duran, A. T., Liyanage-Don, N. A., Torres‐Deas, L. M., Metser, G., Moise, N., Kronish, I. M., & Ye, S. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01814-6 · Cited by 12
Karp, J. F., Kincman, J., Lightfoot, M., Foust, J. E., Maher, R. L., & Gebara, M. A. (2021) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2021.05.015 · Cited by 14
Lowry, S. J., Kay, C. N., Marsom, E. N., Park, J., Poole, S. G., & Page, A. T. (2020) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1695 · Cited by 11
Hatipoğlu, B. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.06.006 · Cited by 10
Pharmacist roles in the medication use process: Perceptions of patients, physicians, and pharmacists
Kim, E., Worley, M. M., & Law, A. V. (2023) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2023.05.013 · Cited by 15
Morris, A., Reed, T., McBride, G., & Chen, J. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.06.056 · Cited by 8
“…enhance accessibility to health care and intervention adherence, such as for medication adherence, as well as to reduce stigma and improve collaboration with consumer support networks, as observed in other mental illnesses (Santesteban-Echarri et al., 2020; Cohen et al., 2020; Young et al., 2021).”
Gazda, N. P., Vest, T. A., Peek, G. K., & Eckel, S. F. (2022) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxac177 · Cited by 7
Marasine, N. R., Sankhi, S., Paudel, S., Chalise, A., & Lamichhane, R. (2025) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2025.100644 · Cited by 7
“Depression severity was evaluated using a variety of validated tools: the Hopkins Symptom Checklist was employed in four studies, 19,23,25,26 the Psychological Health Questionnaire-9 (PHQ-9) in three studies, 26,27,30 and the Beck Depression Inventory (BDI-II) in four studies.”
InfluentialArcoraci, V., Rottura, M., Gianguzzo, V. M., Pallio, G., Imbalzano, E., Nobili, A., Natoli, G., Argano, C., Squadrito, G., Irrera, N., et al. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105602 · Cited by 7
Gityamwi, N., Armes, J., Harris, J., Ream, E., Green, R., Ahankari, A. S., Callwood, A., Ip, A., Cockle‐Hearne, J., Grosvenor, W., et al. (2025) · PLOS Digital Health · doi:10.1371/journal.pdig.0000806 · Cited by 6
Alessi, J., Becker, A. S., do Amaral, B. B., de Oliveira, G. B., Franco, D. W., Knijnik, C. P., Kobe, G. L., de Brito, A., de Carvalho, T. R., Teló, G. H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07005-w · Cited by 5
RetractedAlessi, J., Becker, A. S., do Amaral, B. B., de Oliveira, G. B., Franco, D. W., Knijnik, C. P., Kobe, G. L., de Brito, A., de Carvalho, T. R., Teló, G. H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-12227-z · Cited by 6
Kwakye, A. O., Larry-Afutu, J. A., & Kretchy, I. A. (2025) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.70016 · Cited by 5
“…diverse adherence interventions, such as telehealth, virtual reminders, pharmacological support, and behavioural therapies like CBT. Telehealth interventions, as shown elsewhere, 30,34 appear promising in enhancing adherence, particularly in contexts where patients had mobility or time constraints.”
A narrative review: Pharmacy intervention fidelity
Rickles, N. M., Sharma, M., Harrow, S., & Silverwatch, J. (2022) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2022.10.010 · Cited by 4
Okere, A. N., Balogun, A., Smith, A., & Stevens, J. (2023) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2023.200206 · Cited by 7
“[25] (USA) Open label Randomized Control Study Telephone Veterans with type 1 or type 2 diabetes, an A1C ≥ 7.”
BackgroundPost hoc depression analysis from a pharmacist-led diabetes trial
Bateman, M. T., McCarthy, C. M., Prioli, K. M., & Wagner, M. (2023) · Mental Health Clinician · doi:10.9740/mhc.2023.02.018 · Cited by 5
The Effect of Pharmacist-Led Telemedicine on A1c Reduction During the COVID-19 Pandemic
Ahmed, F., Hammad, S., Redmann, O., Smith, C., Edwards, C. A., Kader, C., Hammoudeh, D., & Zeidan, R. S. (2023) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2023.0043 · Cited by 6
“18 Another single-center, prospective study evaluated the impact of a pharmacist-led Clinical Video Telehealth (CVT) program for chronic disease state management, which revealed 6 months of CVT clinic attendance significantly improved A1C values and the overall percentage (38”
Application of Pharmacogenomics Testing in a Community-based Facility
Wang, J., Paul, S., Arbet, R. N., & Lin, A. C. (2022) · Hospital Pharmacy · doi:10.1177/00185787221134693 · Cited by 5
Sherazi, B. A., Sayyed, S. A., Möllenhoff, K., & Läer, S. (2024) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s468881 · Cited by 4
Kiebach, A. M., McAlpine, T. E., Cavanaugh, M. H., & Benzer, J. A. (2024) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.2046 · Cited by 2
AL-Hawamdeh, M. I., Raiisi, F. A., Adawi, R. M. A., Abu‐Huwaij, R., & Tonna, A. P. (2025) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-025-02056-1 · Cited by 1
“Of the 10 included studies, five focused exclusively on patients with type 2 diabetes [26–29, 32”
InfluentialAmanollahzadeh, A., Alilu, L., & Khalkhali, H. R. (2022) · Nursing and Midwifery Journal · doi:10.52547/unmf.20.8.645 · Cited by 1
Henley, N., Chen-Maynard, D., & Pablo-Bandong, E. (2022) · Telehealth and Medicine Today · doi:10.30953/tmt.v7.309 · Cited by 2
“(12) showed that the pharmacist- and nurseled telehealth program resulted in a significant medical adherence and a significant difference in plasma A1C in patients with diabetes.”
BackgroundA systematic review of interventions to improve medication adherence in family medicine patients
Alrashidi, A. S., Alasmari, H. D. H., Alshammari, A. M., & Alrashedi, K. S. (2023) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2023.95256199 · Cited by 1
Tổng quan hệ thống về các dịch vụ dược từ xa trên bệnh nhân ngoại trú mắc bệnh mạn tính
Thao, N. T. T. (2023) · Journal of 108 - Clinical Medicine and Phamarcy · doi:10.52389/ydls.v18idbv.2000
Patel, A. D., Joshi, C., Das, R. R., Stern, J. M., Herman, S. T., & Gidal, B. E. (2024) · Epiliepsy currents/Epilepsy currents · doi:10.1177/15357597241255274
Diabetes Technology in the Geriatric Population
Pisano, M., Mazzola, N., & Nguyen, N. M. (2024) · Contemporary Endocrinology · doi:10.1007/978-3-031-75352-7_7
Silvia, R. J., Mohammad, I., English, C., Bradley, B. A., Ottney, A. R., & Crismon, M. L. (2025) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.70009
Saldanha, A. Z., Boggiss, A. L., & Serlachius, A. S. (2026) · Patient Education and Counseling · doi:10.1016/j.pec.2026.109659
Alakhras, L., Hasan, S., Hussein, S., & Bader, S. (2026) · International Journal of Pharmacy Practice · doi:10.1093/ijpp/riag069 · Cited by 1
Metadata
- Authors
- Cohen, L. B., Taveira, T. H., Wu, W.-C., & Pirraglia, P. A.
- Affiliations
- University of Rhode Island (US)
- Brown University (US)
- United States Department of Veterans Affairs (US)
- Corresponding author
- Cohen, Lisa B
- Venue
- Journal of Telemedicine and Telecare
- Publisher
- SAGE Publications
- Published
- 2019-01-28
- Volume
- 26
- Issue
- 5
- Pages
- 294-302
- ISSN
- 1357-633X (ISSN-L)
- 1758-1109
- OpenAlex
- W2913573181
- Cited by
- 48
- References
- 28
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 9 · 2023: 11 · 2022: 14 · 2021: 5 · 2020: 1
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Telemedicine and Telecare (publishedVersion)
- PubMed (publishedVersion)
- Journal of Media Literacy Education (submittedVersion, cc-by)
- Funders
- ASHP Research and Education Foundation (Young Federal Investigators Award)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- diabetes mellitus, depression, medication adherence, HbA1c, medication review, veterans, antidepressants, cardiovascular drugs, PHQ-9, CES-D
- MeSH terms
- Assessment of Medication Adherence, Depression, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Pharmacists, Veterans, Drug Monitoring, Telemedicine, Disease Management, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.